𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled trial of thymostimulin and adenine arabinoside monophosphate for type B hepatitis


Book ID
122770559
Publisher
Elsevier Science
Year
1987
Tongue
English
Weight
70 KB
Volume
5
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Adenine arabinoside 5β€²-monophosphate tre
✍ Jay H. Hoofnagle; Gerald Y. Minuk; Geoffrey M. Dusheiko; Daniel F. Schafer; Rodn πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 489 KB

Six patients with chronic type B hepatitis were treated with adenine arabinoside 5'-monophosphate at a dosage of 10 to 15 mg per kg per day for 10 days. All demonstrated an immediate and marked decrease in serum hepatitis B virus DNA and DNA polymerase, and 5 of the 6 became negative for both marker

Treatment of chronic type B hepatitis wi
✍ Jay H. Hoofnagle; Gary L. Davis; Reginald G. Hanson; S. Chris Pappas; Marion G. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 533 KB

Ten patients with chronic type B hepatitis were treated with three courses of adenine arabinoside monosphosphate (Ara-AMP). The drug was given intramuscularly at a dosage of 10 mg/kg/day in ten-day courses during each of three sequential months. The patients were all men, aged 31-61 years, who were

Randomized controlled trial of adenine a
✍ Patrick Marcellin; Denis Ouzan; FranΓ§oise Degos; Christian Brechot; Etienne-Henr πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 459 KB πŸ‘ 1 views

Twenty-two heterosexuals and 2 1 homosexuals with chronic active hepatitis B and who had HBsAg, HBeAg and hepatitis B virus DNA in serum were randomized separately to receive adenine arabinoside monophosphate or placebo. In the 10 heterosexuals and nine homosexuals who received placebo, no change in